InvestSMART

Optiscan Imaging Limited (ASX: OIL) - Announcements

- Current share price for OIL : $0.175

ASX company news and announcements for Optiscan Imaging Limited (OIL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Optiscan Imaging Limited (OIL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Optiscan Imaging Limited (OIL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Optiscan Imaging Limited (OIL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$183 Change in substantial holding 17 Mar 2026 3:46PM $0.085 $0.175 risen by 105.88%
$183 Half Year Report - 31 December 2025 25 Feb 2026 9:51AM $0.086 $0.175 risen by 103.49%
$183 Appendix 4D 25 Feb 2026 9:49AM $0.086 $0.175 risen by 103.49%
$183 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2026 9:14AM $0.091 $0.175 risen by 92.31%
$183 Change of Director's Interest Notice x4 15 Jan 2026 6:22PM $0.095 $0.175 risen by 84.21%
$183 Notification regarding unquoted securities - OIL 15 Jan 2026 6:14PM $0.095 $0.175 risen by 84.21%
$183 Change of Director's Interest Notice 29 Dec 2025 1:04PM $0.097 $0.175 risen by 80.41%
$183 Investor Presentation 4 Dec 2025 1:58PM $0.110 $0.175 risen by 59.09%
$183 Optiscan Initiates Head & Neck Cancer Imaging Study 3 Dec 2025 8:29AM $0.115 $0.175 risen by 52.17%
$183 OIL Investor Webinar Invite 1 Dec 2025 3:12PM $0.115 $0.175 risen by 52.17%
$183 OIL Results of Annual General Meeting 14 Nov 2025 3:25PM $0.115 $0.175 risen by 52.17%
$183 OIL 2025 AGM Presentation 14 Nov 2025 10:39AM $0.125 $0.175 risen by 40%
$183 Optiscan Partners with ACL to Advance Digital Pathology 10 Nov 2025 11:08AM $0.115 $0.175 risen by 52.17%
$183 Quarterly Activities/Appendix 4C Cash Flow Report 28 Oct 2025 9:35AM $0.110 $0.175 risen by 59.09%
$183 Notice of Annual General Meeting/Proxy Form 15 Oct 2025 12:49PM $0.120 $0.175 risen by 45.83%
$183 Change of Director's Interest Notice x4 29 Sep 2025 4:51PM $0.085 $0.175 risen by 105.88%
$183 Optiscan ASX Small and Mid-Cap Conference Presentation 24 Sep 2025 9:41AM $0.081 $0.175 risen by 116.05%
$183 Issue of New Shares under the Rights Issue 23 Sep 2025 10:53AM $0.080 $0.175 risen by 118.75%
$183 Application for quotation of securities - OIL 23 Sep 2025 10:52AM $0.080 $0.175 risen by 118.75%
$183 Rights Issue Closure and Shortfall Notification 19 Sep 2025 10:50AM $0.081 $0.175 risen by 116.05%
$183 Letter to Ineligible Shareholders 5 Sep 2025 12:08PM $0.090 $0.175 risen by 94.44%
$183 Optiscan Despatches Entitlement Offer Documents 5 Sep 2025 12:07PM $0.090 $0.175 risen by 94.44%
$183 Appendix 4G & Corporate Governance Statement 29 Aug 2025 3:08PM $0.085 $0.175 risen by 105.88%
$183 2025 Annual Report 29 Aug 2025 3:08PM $0.085 $0.175 risen by 105.88%
$183 Appendix 4E - Preliminary Final Report 29 Aug 2025 3:05PM $0.085 $0.175 risen by 105.88%

26 - 50 of 633 results

Page 2 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.